“Correlation Analysis of DNA UGT1A1 Gene Expression in Hyperbilirubinemia and Central Nervous System-Related Adverse Reactions Following Oral Dolutegravir Administration”, MEDIN, vol. 1, no. 1, pp. 35–42, Oct. 2023, doi: 10.47852/bonviewMEDIN32021466.